|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01187 COFOE MEDICAL
Nominal 
31.700 +0.140 (+0.444%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | |
| Turnover | 2,071,848 | 38.514% | 1,495,764 |
| Cost of Sales | (940,722) | 25.767% | (747,987) |
| Gross Profit | 1,131,126 | 51.265% | 747,777 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | |
| Change in FV & Impairment on Others | 18,839 | 92.470% | 9,788 | |
| Profit / (Loss) on Disposal | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (6,228) | -- | 643 | |
| Profit / (Loss) before Taxation | 244,070 | 22.243% | 199,659 | |
| Taxation | (40,871) | 23.791% | (33,016) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | |
| Non-controlling Interests | (935) | -- | 745 | |
| Others | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 202,264 | 20.835% | 167,388 | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | |
| Net Finance Costs / (Income) | (4,470) | -8.626% | (4,892) |
| Depreciation & Amortisation | 103,237 | 10.305% | 93,592 |
| Directors' Emoluments | -- | -- | -- |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | |
| Auditor's Opinion Status | N/A | -- | N/A |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | |
| EPS (cts) | 95.000 | 15.854% | 82.000 |
| DPS (cts) | 60.000 | -- | -- |
| Dividend Payout Ratio (%) | 63.158% | -- | -- |
| Cash flow per share ($) | -- | -- | -- |
| NBV per share ($) | 24.166 | -- | -- |
| Remarks: | Real time quote last updated: 10/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 202,264 |
| %Change | 20.835% |
| EPS / (LPS) | RMB 0.950 |
| NBV Per Share (¥) | RMB 24.166 |